Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features
Journal of Clinical Endocrinology & Metabolism | Aug 13, 2018
ACTIVExtend: 24 months of alendronate after 18 months of abaloparatide or placebo for postmenopausal osteoporosis
Journal of Clinical Endocrinology & Metabolism | Aug 12, 2018
GH therapy in childhood cancer survivors: A systematic review and meta-analysis
Journal of Clinical Endocrinology & Metabolism | Aug 11, 2018
Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: A randomised, placebo-controlled clinical trial
Diabetologia - Clinical and Experimental Diabetes and Metabolism | Aug 07, 2018